~統合再編から世界に向けて~

福島県立医科大学 消化管外科学講座

業績

ホーム > 業績 > 業績集 消化管外科学講座 令和元年(2019年)

業績集 消化管外科学講座 令和元年(2019年)

(分類は大学の業績集に準じています)

(1) 論文

①原著 (筆頭著者のイニシアル順)
1. Ashizawa M, Okayama H, Ishigame T, Aung Kyi TM, Saito K, Ujiie D, Murakami Y, Kikuchi T, Nakayama Y, Noda M, Tada T, Endo H, Fujita S, Sakamoto W, Saito M, Saze Z, Momma T, Ohki S, Mimura K, Kono K. miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1. Mol Cancer Res. 17(6): 1403-1413, 2019.
2. Ashizawa M, Saito M, Aung Kyi TM, Ujiie D, Saito K, Sato T, Kikuchi T, Okayama H, Fujita S, Endo H, Sakamoto W, Momma T, Ohki S, Goto A, Kono K. Prognostic role of ARID1A negative expression in gastric cancer. Sci Rep. 1(9): 6769, 2019.
3. Gonda K, Yaginuma K, Rokkaku Y, Horita S, Maejima Y, Shimomura K. Association between cognitive impairment patient with solid cancer and insulin resistance. BMC Res Notes. 12(1): 705, 2019.
4. Hayase S, Yamada L, Ujiie D, Nirei A, Tada T, Hanayama H, Momma T, Saze Z, Ohki S, Kono K. Clinical usefulness of ramucirumab plus paclitaxel for unresectable and recurrent gastric cancer. Fukushima J Med Sci. 65(1): 6-12, 2019.
5. Ishimaru K, Nakajima S, Yu G, Nakamura Y, Nakao A. The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock. Int J Mo Sci. 20(24), 2019.
6. Ito T, Kono K, Eguchi H, Okazaki Y, Yamamoto G, Tachikawa T, Akagi K, Okada Y, Kawakami S, Morozumi M, Tamaru J, Ishida H. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population. Jpn J Clin Oncol. 2019.
7. Kanke Y, Saito M, Abe N, Saito K, Goto A, Ohtake T, Murakami Y, Kono K. Expression profile of CADM1 and CADM4 in triple negative breast cancer with primary systemic therapy. Oncol Lett. 17(1): 921-926, 2019.
8. Kikuchi T, Mimura K, Ashizawa M, Okayama H, Endo E, Saito K, Sakamoto W, Fujita S, Endo H, Saito M, Momma T, Saze Z, Ohki S, Shimada K, Yoshimura K, Tsunoda T, Kono K. Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers. Cancer Immunol Immunother. 69(1): 23-32, 2020.
9. Kikuchi T, Mimura K, Okayama H, Nakayama Y, Saito K, Yamada L, Endo E, Sakamoto W, Fujita S, Endo H, Saito M, Momma T, Saze Z, Ohki S, Kono K. A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ. Oncol Lett. 18(6): 59775985, 2019.
10. Minamikawa K, Okumura A, Kokudo N, Kono K. Regulation on introducing process of the highly difficult new medical technologies: A survey on the current status of practice guidelines in Japan and overseas. Biosci Trends. 12(6): 560-568, 2019.
11. Nakajima S, Ishimaru K, Kobayashi A, Yu G, Nakamura Y, Oh-oka Y, Suzuki-Inoue K, Kono K, Nakao A. Resveratrol inhibits IL-33-mediated mast cell activation by targeting the MK2/3-PI3K/Akt axis. Sci Rep. 9(1): 18423, 2019.
12. Nakayama Y, Mimura K, Takamaki T, Shiraishi K, Kua LF, Koh V, Ohmomri M, Kimura A, Inoue S, Okayama H, Suzuki Y, Kanazawa T, Ujiie D, Kono K. PhosphoSTAT1 expression as a potential biomarker for antiPD1/antiPDL1 immunotherapy for breast cancer. Int J Oncol. 54(6): 2030-2038, 2019.
13. Okano M, Oshi M, Butash AL, Katsuta E, Tachibana K, Saito K, Okayama H, Peng X, Yan L, Kono K, Ohtake T, Takabe K. Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis. Int J Mol Sci. 20(17): 4197,2019.
14. Okonogi N, Suzuki Y, Sato H, Oike T, Yoshimoto Y, Mimura K, Noda SE, Okamoto M, Tamaki T, Morokoshi Y, Hasegawa S, Ohgaki H, Yokoo H, Nakano T. In Reply to Minhas and Tran. Int J Radiat Oncol Bio Phys. 104(1): 223-224 ,2019.
15. Pydi SP, Jain S, Tung W, Cui Y, Zhu L, Sakamoto W, Jain S, Abel BS, Skarulis MC, Liu J, Huynh T, Pacak K, Caron MG, Gavrilova O, Finkel T, Wess J. Adipocyte β-arrestin-2 is essential for maintaining whole body glucose and energy homeostasis. Nat Commun. 10(1): 2936, 2019.
16. Sakamoto W, Yamada L, Suzuki O, Kikuchi T, Okayama H, Endo H, Fujita S, Saito M, Momma T, Saze Z, Ohki S, Kono K. Microanatomy of inferior mesenteric artery sheath in colorectal cancer surgery. J Anus Rectum Colon. 3(4): 167-174, 2019.
17. Satake S, Shimura T, Ono T, Shimomura K, Takenoshita S,Kono K. Noninvasive continuous blood pressure monitoring using microelectromechanical system technology. Blood Press Monit. 24(3): 155-159, 2019.
18. Shimura T, Shibata M,Gonda K, Murakami Y, Noda M, Tachibana K, Abe N, Ohtake T. Prognostic impact of interleukin-6 and C-reactive protein on patients with breast cancer. Oncol Lett. 17(6): 5139-5146, 2019.
19. Soeda S, Furukawa S, Sato T, Ueda M, Kamo N, Endo Y, Kojima M, Nomura S, Kataoka M, Fujita S, Endo H, Takahashi T, Watanabe T, Yamada H, Fujimori K. Pelvic Exenteration as Potential Cure and Symptom Relief in Advanced and Recurrent Gynaecological Cancer. Anticancer Res. 39(10): 5631-5637, 2019.
20. Tan YJ, Lee YT, Petersen SH, Kaur G, Kono K, Tan SC, Majid AMSA, Oon CE. BZD9L1 sirtuin inhibitor as a potential adjuvant for sensitization of colorectal cancer cells to 5-fluorouracil. Ther Adv Med Oncol. 11: 1-25, 2019.
21. Ujiie D, Okayama H, Saito K, Ashizawa M, Aung Kyi TM, Endo E, Kase K, Yamada L, Kikuchi T, Hanayama H, Fujita S, Sakamoto W, Endo, H, Saito M, Mimura K, Saze Z, Momma T, Ohki S, Kono K. KRT17 as a prognostic biomarker for stage II colorectal cancer. Carcinogenesis. 2019.
22. Yamada L, Saito M, Aung Kyi TM, Saito K, Kase K, Onozawa H, Okayama H, Fujita S, Endo H, Sakamoto W, Saze Z, Momma T, Ohki S, Mimura K, Kono K. Explore the correlation between ARID1A and ANXA1 expressions in gastric cancer. Ann. Cancer Res.Ther. 27(2):48-51, 2019.
1. 木村隆, 横山斉, 鈴木眞一, 河野浩二, 丸橋 繁, 鈴木弘行, 大竹徹, 田中秀明. 外科医となる自信を涵養する外科臨床実習-時代にマッチした外科医のリクルート-. 日本外科学会雑誌. 80(12): 2175-2182, 2019.
②総説等
1. Saito M, Kono K, Kohno T. Molecular Genetics of Thymic Carcinoma. eLS. 2019.
2. Shibata M, Mimura K, Shimura T, Kono K, Ohto H, Takenoshita S. IL-17A in oncology. Ann. Cancer Res. Ther. 27(2): 59-63, 2019.
③症例報告
1. Asano T, Sato S, Furuya MY, Takahashi H, Shichishima-Nakamura A, Ohkawara H, Fujiwara T, Gunji N, Hashimoto C, Momma T, Saito M, Nakano H, Watanabe G, Temmoku J, Fujita Y, Matsuoka N, Kobayashi H, Watanabe H, Mouri M, Mashiyama F, Sakuma H, Ohira H, Mori M, Ikezoe T, Migita K. Intestinal Behcet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation: A case report. Medicine. 98(46): e17979, 2019.
2. Gonda K, Akama T, Nakamura T, Hashimoto E, Kyoya N, Rokkaku Y, Maejima Y, Horita S, Tachibana K, Abe N, Ohtake T, Shimomura K, Kono K, Saji S, Takenoshita S, Higashihara E. Cluster of differentiation 8 and programmed cell death ligand 1 expression in triple-negative breast cancer combined with autosomal dominant polycystic kidney disease and tuberous sclerosis complex: a case report. J Med Case Rep. 13(1): 381. 2019.
3. Kawashima K, Fujiwara T, Katakura K, Gunji N, Yokokawa A, Sakamoto W, Hikichi T, Kono K, Ohira H. A Case of Anisakiasis in the Small Intestine with Excessive Bleeding That was Difficult to Diagnose Endoscopically. Internal Medicine. 58(1): 63-66,2019.
4. Momma T, Gonda K, Akama Y, Endo E, Ujiie D, Fujita S, Maejima Y, Horita S, Shimomura K, Saji S, Kono K, Yashima R, Watanabe F, Sugano K, Nomizu T. MLH1 germline mutation associated with Lynch syndromae in a family followed for more than 45 years. BMC Medical Genetics. 20: 67, 2019.
5. 深井智司, 絹田俊爾, 林嗣博, 滝口光一, 羽成直行, 輿石直樹. 腹腔鏡下幽門側胃切除術を施行した左胃動脈・冠動脈交通を伴う胃癌の1例. 日本臨床外科学会雑誌. 80(1): 67-73, 2019.
6. 藤田正太郎, 門馬智之, 佐藤孝洋, 遠藤英成, 加瀬晃志, 氏家大輔, 菊池智宏, 楡井東, 花山寛之, 渡辺洋平, 岡山洋和, 坂本渉, 遠藤久仁, 齋藤元伸, 佐瀬善一郎, 大木進司, 河野浩二. 直腸癌術後の直腸膣痩に対しエストリオール膣錠と膣洗浄にて治癒した1例. 癌と化学療法 . 46(13): 2078-2080, 2019.
7. 松井田元, 土屋貴男, 齋藤敬弘, 大谷聡, 伊東藤男, 三浦純一. 内視鏡治療により治癒し得た魚骨によるS状結腸穿通の1例. 福島医学雑誌. 69(2): 161-166, 2019.
8. 松本拓朗, 大木進司, 門馬智之, 喜古雄一郎, 田﨑和洋, 河野浩二. 小網原発GISTの2例. 日本臨床外科学会雑誌. 80(12): 2175-2182, 2019.
9. 松本拓朗, 圓谷秀哲, 伊藤泰輔, 石井芳正, 小田島肇, 河野浩二. 胃びまん性大細胞型B細胞性リンパ腫に併存した胃GISTの1例. 日本臨床外科学会雑誌. 80(11): 2006-2012, 2019.

(2) 著書・訳書

1. Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 1. Esophagus. 16(1): 1-24, 2019.
2. Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus. 16(1): 25-43, 2019.
3. 大木進司, 氏家大輔, 松本拓朗, 仲野宏, 河野浩二. EBウィルス関連胃癌. 別冊 日本臨床 領域別症候群シリーズ No.9 消化管症候群(第3版)Ⅰ -その他の消化管疾患を含めて-. 284-287, 2019.
4. 河野浩二, 柴田昌彦. 【癌免疫カンファレンスルーム】連載を終えるにあたって. 消化器外科. 42(11): 1610-1611, 2019.
5. 河野浩二, 南川一夫, 冨樫順一, 長谷川潔, 國土典宏. 【医療機器・介護機器開発を正しくおこなうための関連法とガイドラインの理解】高難度新規医療技術の導入プロセスが制度化された背景について. 医療機器学. 89(4): 383-387, 2019.
6. 佐瀬善一郎, 河野浩二. 【最新の診断技術】食道癌リンパ節転移診断の進歩. 日本外科学会雑誌. 120(3): 343-344, 2019.
7. 柴田昌彦. 【癌と炎症を学ぶ第1回】“癌と炎症” 概説;連載の序にかえて. 消化器外科. 42(12): 1723-1729, 2019.
8. 中山裕子, 三村耕作, 河野浩二. 【がんにおけるPD-L1分子の発現調節】IFN-γの観点からみたPD-L1発現機構と抗PD-1/抗PD-L1抗体のバイオマーカー開発. 癌と化学療法. 46(5): 838-840, 2019.

(3) 知的財産権

1. 氏家大輔, 岡山洋和, 河野浩二. 出願番号:特願2019-021987 発明の名称:大腸がんの予後バイオマーカー.
2. 竹之下誠一, 大木進司. 特許第6618468号 発明の名称:能動鉗子.

お問い合わせcontact

ご相談・ご質問などお気軽にお寄せください

公立大学法人福島県立医科大学 消化管外科学講座
〒960-1295 福島県福島市光が丘1
TEL 024-547-1259
MAIL gi-tsurg@fmu.ac.jp